A case of dyspnea: respiratory failure due to pulmonary arteriovenous malformation by Lucio, Brugioni et al.
Introduction
Pulmonary arteriovenous malformations
(PAVMs) allow a proportion of the right ventricular
volume to bypass gas exchange, filtration, and other
functions of the pulmonary capillary bed. The size of
the right-to-left shunt determines the degree of hy-
poxemia and respiratory failure. PAVMs of any size
allow paradoxical emboli that may cause ischemic
strokes, myocardial infarction, cerebral (brain) and
peripheral abscesses. Less frequently, PAVMs may
cause hemoptysis, hemothorax, and/or maternal
death in pregnancy. Due to compensatory adapta-
tions, respiratory symptoms are frequently absent or
not recognized.
The differential diagnosis of PAVMs is wide and
depends on the presenting complaint. Although
PAVMs are unusual causes of pulmonary nodules,
dyspnea, hemoptysis, stroke, and cerebral abscess,
they should be suspected when more common etiolo-
gies for these symptoms and signs are absent.
Case Report
A 19-year-old man presented to the Emergency
Department after occasional finding of poly-
cythemia (hemoglobin 19.8 gr/dL, hematocrit 59%)
and persistent hypoxemia (SaO2 <85%) even though
he underwent supplemental oxygen therapy. In his
medical history, only autoimmune thyroiditis is re-
ported. The clinical exam revealed clubbing fingers;
also, his grandfather presented this sign. The arterial
blood gas test showed hypoxemic respiratory failure
with respiratory alkalosis (pH 7.45, pO2 46 mmHg,
pCO2 29 mmHg, SpO2 83%, HCO3 22.5 mmol/L).
Metabolic panel, thoracic X-rays, electrocardiogram
and echocardiography were all normal. Angio-com-
puted tomographic (CT) scan of the chest detected
multiple PAVMs in subsegmental arteries and veins
of the left lung with marked dilatation of the left pul-
monary vein. Saline bubble contrast echocardiogra-
phy (TTCE) showed severe PAVM with right-to-left
shunt. The patient was treated with injection of em-
bolic material by selective angiographic catheteri-
zation of the biggest PAVMs (embolotherapy). The
procedure was repeated after few months to com-
plete the closure of remaining PAVMs. The patient
subsequently was in good general conditions,
asymptomatic for dyspnea, with persistent mild de-
saturation on exertion. Other tests were made for de-
tecting other PAVMs associated with hereditary
hemorrhagic telangiectasia (HHT), in particular in
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splanchnic and cerebral districts, which were
normal.
Discussion
Pulmonary arteriovenous malformations are ab-
normal communications between pulmonary arteries
and veins. Approximately 80-95% of PAVMs are as-
sociated with HHT,1,2 also known as Osler-Weber-
Rendu syndrome. PAVMs may be present from birth
and have usually completed major development by
adult life, although they can enlarge later in life, for
example, during pregnancy or other alterations in
pulmonary hemodynamics.3 The clinical features
suggestive of PAVMs are stigmata of right-to-left
shunting (dyspnea, hypoxemia, cyanosis, cerebral
embolism, brain abscess), unexplained hemoptysis
or hemothorax.4
These include life-threatening hemorrhage,
symptoms and complications from paradoxical em-
bolization, such as stroke and brain abscess. The pri-
mary determinants of stroke and abscess risks were
unrelated to severity of PAVMs. There was a mar-
ginal association between brain abscess and low oxy-
gen saturation. For ischemic stroke, there was no
association with any marker of PAVM severity, or
with conventional neurovascular risk factors. Sur-
prisingly, low mean pulmonary artery pressure was
strongly associated with ischemic stroke.5 Although
the literature prior to 20006 suggested that most
PAVMs were associated with pulmonary symptoms,
studies since 2000 describe pulmonary symptoms in
only 20 to 65 percent (approximately 40 percent) of
patients, and the remainder are asymptomatic, and
they are typically found incidentally upon chest im-
aging.7 For most patients with suspected PAVMs, the
initial test of choice to evaluate the presence of a
right-to-left shunt is TTCE (also known as bubble
echocardiography). This test has high sensitivity and
so it is the reason why TTCE was recommended by
the international HHT guidelines committee as the
initial PAVM screening test.8 Although PAVMs may
be clearly visible on chest radiographs, many are not,
and the chest radiograph has been reported as being
normal in 10 to 40% of instances where clinically
significant PAVMs were present.9 CT is generally
considered the gold standard investigation for diag-
nosing PAVMs and demonstrating their size and ex-
tent before therapy. This imaging modality defines
PAVM number, size, nature, and suitability for em-
bolization.10 The feeding artery diameter, PAVM-re-
lated symptoms, and the patient’s ability to tolerate
the procedure are the most important factors for se-
lecting patients who are candidates for treatment.
When indicated, most patients are treated with em-
bolotherapy that is recommended for first-line treat-
ment.11 PAVM treatment reduces risks from paradox-
ical emboli and improves oxygenation, other physi-
ological parameters, symptoms exacerbated by
right-to-left shunting and hemorrhage.12 PAVM em-
bolization significantly reduced ischemic stroke
rate.4 Surgery treatment is another option in case of
embolization failure. 
Conclusions
PAVMs are uncommon in the general population,
but they need to be considered in differential diag-
nosis of common pulmonary signs and symptoms
such as hypoxemia, pulmonary nodules and hemop-
tysis. PAVMs are often associated with malforma-
tions in other body districts, which need to be
evaluated in case of suspected HHT syndrome.
PAVMs morbidity and mortality are related to the
development of serious complications including
stroke, brain abscess, chronic hypoxemic respiratory
failure and life-threatening hemoptysis or hemo-
thorax.
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